183 related articles for article (PubMed ID: 15585368)
1. The in vivo cardiovascular effects of the Irukandji jellyfish (Carukia barnesi) nematocyst venom and a tentacle extract in rats.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicol Lett; 2005 Jan; 155(1):135-41. PubMed ID: 15585368
[TBL] [Abstract][Full Text] [Related]
2. An examination of the cardiovascular effects of an 'Irukandji' jellyfish, Alatina nr mordens.
Winter KL; Isbister GK; Schneider JJ; Konstantakopoulos N; Seymour JE; Hodgson WC
Toxicol Lett; 2008 Jul; 179(3):118-23. PubMed ID: 18547753
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologically distinct cardiovascular effects of box jellyfish (Chironex fleckeri) venom and a tentacle-only extract in rats.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicol Lett; 2005 Feb; 155(2):219-26. PubMed ID: 15603916
[TBL] [Abstract][Full Text] [Related]
4. The in vivo cardiovascular effects of an Australasian box jellyfish (Chiropsalmus sp.) venom in rats.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2005 Mar; 45(3):321-7. PubMed ID: 15683870
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular actions of the venom from the Irukandji (Carukia barnesi) jellyfish: effects in human, rat and guinea-pig tissues in vitro and in pigs in vitro.
Winkel KD; Tibballs J; Molenaar P; Lambert G; Coles P; Ross-Smith M; Wiltshire C; Fenner PJ; Gershwin LA; Hawdon GM; Wright CE; Angus JA
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):777-88. PubMed ID: 16173936
[TBL] [Abstract][Full Text] [Related]
6. The in vivo cardiovascular effects of box jellyfish Chironex fleckeri venom in rats: efficacy of pre-treatment with antivenom, verapamil and magnesium sulphate.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2004 May; 43(6):685-90. PubMed ID: 15109889
[TBL] [Abstract][Full Text] [Related]
7. Cyanea capillata tentacle-only extract as a potential alternative of nematocyst venom: its cardiovascular toxicity and tolerance to isolation and purification procedures.
Xiao L; He Q; Guo Y; Zhang J; Nie F; Li Y; Ye X; Zhang L
Toxicon; 2009 Jan; 53(1):146-52. PubMed ID: 19026672
[TBL] [Abstract][Full Text] [Related]
8. An in vivo comparison of the efficacy of CSL box jellyfish antivenom with antibodies raised against nematocyst-derived Chironex fleckeri venom.
Winter KL; Isbister GK; Jacoby T; Seymour JE; Hodgson WC
Toxicol Lett; 2009 Jun; 187(2):94-8. PubMed ID: 19429250
[TBL] [Abstract][Full Text] [Related]
9. Venom ontogeny, diet and morphology in Carukia barnesi, a species of Australian box jellyfish that causes Irukandji syndrome.
Underwood AH; Seymour JE
Toxicon; 2007 Jun; 49(8):1073-82. PubMed ID: 17395227
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
Yalcin M; Aydin C
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of Nemopilema nomurai (Scyphozoa: Rhizostomeae) jellyfish venom in rats.
Kim E; Lee S; Kim JS; Yoon WD; Lim D; Hart AJ; Hodgson WC
Toxicol Lett; 2006 Dec; 167(3):205-11. PubMed ID: 17069996
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of Malo maxima jellyfish venom extract in isolated cardiovascular tissues: A probable cause of the Irukandji syndrome in Western Australia.
Li R; Wright CE; Winkel KD; Gershwin LA; Angus JA
Toxicol Lett; 2011 Mar; 201(3):221-9. PubMed ID: 21237252
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of scorpionfish (Scorpaena plumieri) venom.
Gomes HL; Andrich F; Mauad H; Sampaio KN; De Lima ME; Figueiredo SG; Moysés MR
Toxicon; 2010; 55(2-3):580-9. PubMed ID: 19879286
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral hemorrhage and death after envenoming by the jellyfish Carukia barnesi.
Pereira P; Barry J; Corkeron M; Keir P; Little M; Seymour J
Clin Toxicol (Phila); 2010 May; 48(4):390-2. PubMed ID: 20507250
[TBL] [Abstract][Full Text] [Related]
15. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
Moreira TS; Takakura AC; Menani JV; Colombari E
Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
[TBL] [Abstract][Full Text] [Related]
16. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
Aydin C; Yalcin M
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
[TBL] [Abstract][Full Text] [Related]
17. An in vivo examination of the stability of venom from the Australian box jellyfish Chironex fleckeri.
Winter KL; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2007 May; 49(6):804-9. PubMed ID: 17215014
[TBL] [Abstract][Full Text] [Related]
18. The lethality of tentacle-only extract from jellyfish Cyanea capillata is primarily attributed to cardiotoxicity in anaesthetized SD rats.
Xiao L; Liu GS; Wang QQ; He Q; Liu SH; Li Y; Zhang J; Zhang LM
Toxicon; 2010 Apr; 55(4):838-45. PubMed ID: 20025895
[TBL] [Abstract][Full Text] [Related]
19. A pharmacological and biochemical examination of the geographical variation of Chironex fleckeri venom.
Winter KL; Isbister GK; McGowan S; Konstantakopoulos N; Seymour JE; Hodgson WC
Toxicol Lett; 2010 Feb; 192(3):419-24. PubMed ID: 19945518
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects and lethality of venom from nematocysts of the box-jellyfish Chiropsalmus quadrigatus (Habu-kurage) in anaesthetized rats.
Noguchi K; Sakanashi M; Matsuzaki T; Nakasone J; Sakanashi M; Koyama T; Hamadate N; Sakanashi M
Toxicon; 2005 Mar; 45(4):519-26. PubMed ID: 15733574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
